Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
497.80
Change Change %
8.00 1.63%

Updated:21 Sep, 2018, 15:59 PM IST

BSE
496.50
Change Change %
6.45 1.32%

Updated:21 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nirmal Bang
N/A
27-06-2016 Buy 1071.35 1234.00
N/A
Target Hit Long (1Y)
27-06-2017

Nirmal Bang initiates Strides Shahun with buy

Shasun Pharmaceutical's merger with Strides Arcolab, which completed in Q3 of last fiscal, will significantly strengthen combined entity Strides Shasun's business model and will bring in a great deal of synergy. Strides Shasun represents a right mix of robust growth, improved return ratios and a strong balance sheet. We value the company at 18 times FY18 estimated EPS of Rs 68.6.

Top